Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Niki BioSolutions(NIKI) the EBIT is -707.28 K (-251.2%);the EPS is -0.814 (-162.7%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B251.21%
----
----
EPS
-0.8141162.67%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf